Trend of Improving Prognosis of Hepatocellular Carcinoma in Clinical Practice: An Italian In-Field Experience
Mauro Borzio(Ospedale Papa Giovanni XXIII), Rodolfo Sacco, E. Dionigi, Anna Toldi(Ospedale Valduce), Susanna Vicari(Presidenza Del Consiglio Dei Ministri), Massimo Marignani(Sapienza University of Rome), Andrea Salmi(Fondazione Poliambulanza Istituto Ospedaliero), Barbara Ginanni(Ospedale Cisanello), Giampiero Francica(Presidio Ospedaliero), Angelo Rossini(Centro Universitário Barão de Mauá), Fabio Farinati(University of Padua), Fulvia Terracciano(Nuovo Ospedale San Giovanni di Dio), Fabio Fornari(Azienda Unità Sanitaria Locale Piacenza)
Cited by 11
Related Papers
Abnormal Liver Function Tests in Patients With COVID‐19: Relevance and Potential Pathogenesis
|Hepatology|2020|302
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept
|The Lancet Oncology|2023|184
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C
|Journal of Hepatology|2018|133
Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study
|The American Journal of Gastroenterology|2002|80